-
481
Nonlinear relationship between hepatic steatosis index and reversion to normal glucose regulation in Chinese adults with prediabetes
Published 2025-02-01Subjects: “…Metabolic associated fatty liver disease…”
Get full text
Article -
482
Liver transplantation for homozygous familial hypercholesterolemia: a retrospective analysis from Chinese experience
Published 2025-01-01Subjects: Get full text
Article -
483
Role of plasma metabolome in mediating the effect of plasma lipidome on NAFLD: a Mendelian randomization study
Published 2025-01-01Subjects: “…nonalcoholic fatty liver disease (NAFLD)…”
Get full text
Article -
484
Corrigendum: Empagliflozin alleviates hepatic steatosis by activating the AMPK-TET2-autophagy pathway in vivo and in vitro
Published 2025-01-01Subjects: “…metabolic associated fatty liver disease…”
Get full text
Article -
485
Effect and Safety of Pioglitazone-Metformin Tablets in the Treatment of Newly Diagnosed Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease in Shaanxi Province: A Randomized, Double-Blinded, Double-Simulated Multicenter Study
Published 2023-01-01“…The aim of study was to evaluate the effect and safety of pioglitazone-metformin combined treatment in the newly diagnosed type 2 diabetes patients with nonalcoholic fatty liver disease. Methods. A total of 120 newly diagnosed type 2 diabetes patients with nonalcoholic fatty liver disease from 8 centers were randomly divided into the control group (metformin hydrochloride) and the test group (pioglitazone hydrochloride and metformin hydrochloride). …”
Get full text
Article -
486
Deep learning helps discriminate between autoimmune hepatitis and primary biliary cholangitis
Published 2025-02-01Subjects: Get full text
Article -
487
Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease
Published 2022-12-01Subjects: “…non-alcoholic fatty liver disease…”
Get full text
Article -
488
The Role of the Liver in the Pathophysiology of PCOS: A Literature Review
Published 2025-01-01Subjects: “…nonalcoholic fatty liver disease (NAFLD)…”
Get full text
Article -
489
Association of daily step counts and step intensity with mortality among US adults: a cross–sectional study of NHANES 2005–2006
Published 2025-01-01Subjects: “…Metabolic dysfunction–associated steatotic liver disease…”
Get full text
Article -
490
FDA’s approval of resmetirom (Rezdiffra): a breakthrough in MASH management
Published 2024-12-01Subjects: “…non-alcoholic fatty liver disease (nafld)…”
Get full text
Article -
491
Development and validation of machine learning models for MASLD: based on multiple potential screening indicators
Published 2025-01-01Subjects: “…metabolic dysfunction-associated steatotic liver disease…”
Get full text
Article -
492
Pre-diabetes and cardiovascular risk factors in NAFLD patients: a retrospective comparative analysis
Published 2025-02-01Subjects: “…non-alcoholic fatty liver disease (NAFLD)…”
Get full text
Article -
493
Age-Dependent Effects of Butyl Benzyl Phthalate Exposure on Lipid Metabolism and Hepatic Fibrosis in Mice
Published 2025-01-01Subjects: “…non-alcoholic fatty liver disease…”
Get full text
Article -
494
Helicobacter pylori Infection and Hepatobiliary Pathology
Published 2018-09-01Subjects: “…non-alcoholic fatty liver disease…”
Get full text
Article -
495
Detectability of Liver Steatosis and Fibrosis with Transient Elastography and Controlled Attenuation Parameter in Residents of St. Petersburg
Published 2021-04-01Subjects: “…non-alcoholic fatty liver disease…”
Get full text
Article -
496
-
497
The fibrosis-4 index and its association with carotid atherosclerosis in type 2 diabetes: a cross-sectional study in China
Published 2025-01-01Subjects: “…Metabolic dysfunction-associated steatotic liver disease…”
Get full text
Article -
498
Activation of the Peroxisome Proliferator-Activated Receptors (PPAR-α/γ) and the Fatty Acid Metabolizing Enzyme Protein CPT1A by Camel Milk Treatment Counteracts the High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease
Published 2021-01-01“…Treatment by CM demonstrated protective effects against nonalcoholic fatty liver disease (NAFLD) induced by a high-fat cholesterol-rich diet (HFD-C) in rats. …”
Get full text
Article -
499
The influence of gender and waist circumference in the association of body fat with cardiometabolic diseases
Published 2025-01-01Subjects: “…Non-alcoholic fatty liver disease (NAFLD)…”
Get full text
Article -
500
Inflammatory lipid biomarkers and transplant-free mortality risk in hepatitis B-related cirrhosis and hepatic encephalopathy
Published 2025-01-01Subjects: Get full text
Article